ABSTRACT. The perinatal ontogeny of preprotachykinin-A gene expression was assessed in central respirationrelated structures. On the day of birth, there was an enhanced expression of preprotachykinin-A mRNA in the region of the nucleus tractus solitarii, the primary relay station for respiratory and cardiovascular reflexes. This increased expression was also seen in the pups delivered by cesarean section and allowed to breathe for a couple of hours as compared with their littermates, which were not allowed to breathe at all. On the basis of this finding, we suggest that the commencement of continuous breathing at birth, unlike the episodic breathing of fetal life, is associ- 
nins are neurokinin-A and neurokinin-B. Substance P and neurokinin-A are encoded by the same gene, PPT-A. PPT-A gene undergoes alternative splicing to give rise to three forms, of which a PPT-A mRNA encodes only for substance P, whereas the Pand 7-PPT-A mRNA encode for both substance P and neurokinin-A (9, 10) . A recent study demonstrated the presence of PPT-A mRNA-containing cells in the nTS and none in the cerebellum (1 1). Significant quantities of substance P-like immunoreactivity was found to be localized in the nTS (1 2), which plays an important role in the reflex transmission of visceral afferent inputs.
The region of the nTS has been shown to receive multiple inputs from peripheral sources such as respiratory, cardiovascular, gustatory, and gastrointestinal systems via the V, VII, IX, and X cranial nerves (13, 14) . Substance P, which is abundant in nTS, is known to mediate baro-and chemoreceptor inputs to the nTS; hypoxic provocation results in an increased release of substance P in the region of nTS (15) . Denervation of the IX and X cranial nerves decreases the immunoreactivity for substance P in the nTS (16) . Thus, substance P has been suggested to have a significant physiologic role in chemo-and baroreceptor transduction mechanisms.
Two distinct populations of substance P-immunoreactive neurons have been described in the ventrolateral medulla: I) a rostra1 group situated ventral to the facial nucleus and 2) a caudal group lying ventrolaterally spanning the rostro-caudal length of the inferior olivary nucleus (17) . In a developmental study on substance P immunoreactivity in the rabbit nTS using the technique of RIA, higher levels have been shown in younger animals than in adults (18) . However, the time points just around birth are lacking in this study. Therefore, a study on the ontogenetic expression of PPT-A mRNA was undertaken especially around the period of birth in rabbit pups. Rabbits, which are known to be precocial developers, closely resemble human infants with regard to the maturation of sleep-wakefulness cycles (1 9).
MATERIALS AND METHODS

Animals.
Rabbit pups of various ages (E31, PO, P1, P3, P8, and adult) were killed with an overdose of pentobarbital. The following regions, depicted in Figure 1 , were rapidly dissected out, frozen on dry ice, and stored at -70°C until processed further: 1) the DRG containing the region of the nTS (however, it should be noted that this area does not specifically contain only nTS and such a resolution could have been obtained by combining with in situ hybridization) where the chemoreceptor afferents terminate; 2) the ventral medullary surface structures where the central chemoreceptors are thought to be located; 3) STR as a hybridizing control; and 4) cerebellum as a negative control area.
In the second set of experiments, pregnant rabbits were anes- was electrophoresed in 1% agarose gels containing 0.7% formaldehyde and transferred to nitrocellulose filters as previously B l5 described (21) . The filters were prehybridized in 4 x SSC (1 x SSC = 0.15M NaC1, 0.0 15M sodium citrate pH 7.0) 40% formlo amide, 1 x Denhardt's solution, 10% dextran sulphate, and 150 pg/mL of denatured sheared single-stranded salmon sperm DNA 
RESULTS
In the region of the DRG, a 380% increase was seen in the level of PPT-A mRNA on PO when compared with E3 1 ( Fig. 2A  and B) . However, on PI there was a decrease by 25% and a further decrease was seen on P3. Although the PPT-A mRNA expression increased on P8, the adult levels were lower than postnatal values, which agrees with RIA studies in the rabbit (1 8) and immunohistochemical findings in the rat (24) . A different ontogenetic pattern was seen in the ventral medullary surface structures. Here the prenatal expression was higher than on the day of birth, then decreased until PI, and thereafter gradually increased until adulthood ( fig. 2A and B) . In the striatum, there was only a 50% increase on PO when compared with E31 ( Fig.   Fig. 2 . Ontogenetic pattern of expression of PPT-A mRNA in DRG, ventral medullary surface structure (VMS), and STR. A, total RNA prepared from the above areas, at the indicated developmental ages, was subjected to electrophoresis in a formaldehyde-containing agarose gel followed by transfer to a nitrocellulose filter. The filter was hybridized to a 32P-labeled rat PPT-A cDNA probe using 2.5 x lo7 cpm of the probe (50 ng) followed by washing and autoradiography. AD, adult. B, developmental pattern of relative amounts of PPT-A mRNA in DRG ventral medullary surface structure (VMS) and STR. Densitometric scannings were performed from two independent experiments as depicted above, one of which is shown in A. In each experiment, the amount of PPT-A mRNA was normalized to the level of actin mRNA. DRG: An enhanced expression is seen on PO as compared with E3 1. VMS: Prenatal expression is higher than on the day of birth. STR: The increased expression seen at PO as compared with E3 1 is lower as compared with the DRG region.
2A and B). In agreement with previous in situ hybridization studies (1 1), no PPT-A mRNA was detected in the cerebellum.
The level of PPT-A mRNA in the region of DRG from pups delivered by cesarean section and not allowed to breathe was
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closely similar to the level of PPT-A mRNA observed at E3 1 in the ontogenetic study reported above. However, the DRG region Fig. 1 . Drawing of the dorsal and ventral surfaces of the brain stem. The outline marked as I mm was the area and thickness of this tissue from the pups that had breathed for 2 h showed a 370% increase removed for Northern blot andysis. Dorsal view: CQA, corpora qua&& in the level of PPT-A mRNA as compared with their nonbreathante"ora; C Q~, corpora quadrigemina poste"ora; XI, nervus ing littermates (Fig. 3) . This is similar to the 380% increase seen accessorius; (a), DRG. Ventral view: PT, pyramidal tract; IO, inferior at PO compared with E3 1 in the ontogenetic study of the DRG olivary nucleus; XI], nervus hypoglossus; Cl, nervus cervicalis primus; region (Fig. 2B) . No difference between the two groups was seen (b), ventral medullary surface structure.
in the STR (Fig. 3) . 
DISCUSSION
The regulation of respiration involves complex interactions of various brainstem nuclei. Conventionally, the major neural structures concerned with the regulation of breathing are located in the medulla in the regions of the nTS, retrofacialis, para-and retroambigualis nuclei, the paragiganto-cellular nuclei involving the structures bordering the ventral surface of the medulla and also the pontine parabrachial area (1 3).
The results presented here are the first evidence that the expression of mRNA encoding a neuromodulator is enhanced in the first few hours after birth. Earlier studies suggest that the substance P-neuron system develops during the prenatal period of ontogeny (25) , long before the establishment of normal synaptic transmission in this area (26). In a study of the developmental characteristics of substance P immunoreactivity within specific brainstem nuclei in the rabbit (18), it was shown that substance P immunoreactivity is highest in the nTS. Higher levels of substance P immunoreactivity were demonstrated postnatally, with a peak at P7 as compared with 4 d before expected delivery in the nTS (18) , but the time points just around the period of birth were not studied. Immunohistochemical studies demonstrate only the level of neuropeptides, which are the net results of synthesis and processing. On the other hand, by analyzing mRNA levels we can directly follow the changes in gene activity that may be the underlying mechanism for the changes in peptide levels.
The peripheral chemoreceptors are active in the fetus in late gestation, but it is interesting to note that peripheral chemodenervation does not affect the incidence of fetal breathing movements (27). The control mechanisms behind the switch from intermittent fetal breathing to continuous postnatal breathing have not yet been elucidated. There appears to be a preponderance of inhibitory transmitters during fetal life, but their effect may be overcome at birth by excitatory neuromodulators like substance P. The question of whether or not the increased expression of the gene for substance P is essential for the control of breathing at birth cannot yet be answered. The fluctuating phenomena seen in the expression of the PPT-A gene, especially in the areas of DRG and STR, suggest either the inhibition of operation of negative feedback loops or the lack of precision of negative control by the known inhibitory neuromodulators of respiration (opioids, dopamine) after birth. However, the fluctuation seen at birth in the area of DRG has been more closely examined and an enhanced expression of PPT-A mRNA was shown to occur 2 h after birth (Fig. 3) It is commonly stated that idiopathic apnea of prematurity develous after the first 24 to 72 h of life and amea that is noted early requires vigorous investigation (1) . The factual basis of this statement is uncertain. Henderson-Smart (2) previously demonstrated that apnea (more than three spells of greater than 20 s duration) developed on the 1st or 2nd postnatal d in 77% of preterm infants. He appears to have used impedance monitoring only and it is uncertain whether any recordings were made for independent confirmation of apnea (3). Carlo et al. (4) , utilizing 60-min recordings, showed that apneic spells of greater than 5 s duration occurred on d 1 in eight of 10 preterm infants without lung disease.
There appears to be no published information regarding the usual frequency and nature of significant apneic spells in an unselected population of healthy newborn preterm infants who have undergone prolonged recordings.
Our main objective was to ascertain the usual age of the appearance of apneic spells and the relative frequency of obstructive, mixed, and central apnea during the 1 st wk of life in preterm infants without respiratory disease. Our secondary objective was to describe the development of respiratory drive, by determining the postnatal progression of occlusion pressures, in infants with and without apnea.
SUBJECTS AND METHODS
Twenty infants of less than 34 wk gestation with birth weights above the 5th percentile for gestational age were studied. Infants were all born in the Royal Alexandra Hospitals and were entered into the study as soon after birth as possible. We entered consecutive infants who were clinically determined to be free of acute medical problems; in particular, they were without significant respiratory disease. The criteria for this were an oxygen requirement of no more than 30%, respiratory rate less than 70/min, and no clinical suspicion of pneumonia or hyaline membrane disease. Infants requiring any supplemental oxygen had chest radiographs, which were required to be normal. Ultrasound examination of the head was performed in all infants before 4 d of age and again at approximately 2 wk of age. Any infant with intraventricular hemorrhage that distended the ventricles or evidence of intracerebral hemorrhage or penventricular leukomalacia on either examination was eliminated from the study.
After the initial clinical examination and assessment to ensure that the infants were stable, each was monitored with a combination of impedance pneumogram, for the detection of chest wall movement, ECG, pulse oximetry (SpOz), and end-tidal COP monitoring; some infants were monitored with transcutaneous POP in addition. The analogue outputs of each of these monitors was digitized by a Data-translation DT2800 analogue to digital convertor board (Data Translation, Inc., Marlborough, MA) and then analyzed on a Compaq 286 personal computer (Compaq Computer Corp., Houston, TX), using programs that we wrote using the Asyst programming language (Asyst Software Industries, Rochdale, NY). At this point, parental consent was sought for the airway occlusion studies and for the continuance of noninvasive monitoring. In the event of parental refusal of the occlusions, consent for continued monitoring alone was requested. This protocol was approved by the clinical investigation committee of the Roval Alexandra Hos~itals.
After obtaining consent, airway occlusions were performed as previously described (5) . A face mask was applied and the absence of leaks was confirmed. Airflow was monitored by means of a Fleisch 00 pneumotachograph and integrated electronically to give tidal volume. At end-extiration the ainvav was occluded Supported by the Northern Alberta Children's Hospital Foundation.
formed as soon as possible after birtfi and then every 12 h for THE APPEARANCE OF APNEA OF PREMATURITY 373 the next 72 h. Thereafter, occlusions were performed daily until the study terminated.
The study continued until the infant was 1 wk old or until therapy (theophylline) for idiopathic apnea of prematurity was prescribed by the attending physician. Thus, all of the results presented herein are from infants who were not receiving methylxanthines or any other therapy for apnea. The clinical staff had no knowledge of the results of the recordings and clinical diagnosis of apnea was according to the usual unit practice of examination of the nursing records.
At the termination of the study, the recordings were analyzed by means of a semiautomated process (6) . The program used will flag an epoch that is considered to contain a potential apneic spell by looking for a combination of any two of the following: loss of end-tidal CO*, fall in heart rate, and fall in Sp02. The epoch may then be visually inspected to determine whether a significant apneic spell was present. The criteria for the diagnosis of a significant apneic spell were as follows: lack of nasal airflow for 15 s accompanied by either a fall in heart rate 20% below the previous mean heart rate or a fall in Sp02 of 10 percentage points. When a spell was identified, its duration and time of occurrence were noted and it was classified into central, obstructive, or mixed. Central spells were those in which there were no obstructed breaths during the apnea. The presence of one or more obstructed respiratory efforts prompted the diagnosis of a mixed or obstructive apneic spell, which were further differentiated by the presence of a period of absent chest wall movement of at least 3 to 4 s duration.
Apnea frequency was calculated on a daily basis. For the first 24 h, the apnea frequency was calculated as the number of apneas noted before 24 h of age divided by the number of hours of recording performed. Thereafter, the apnea frequency was calculated by dividing the daily number of apneas by 24.
Statistical methods included a two-way ANOVA to compare frequencies of apnea with respect to apnea types and postnatal age, with a protected Fisher's least significant difference being used as the post hoc test to define intergroup differences in the event of a significant ANOVA. Pearson correlation coefficient was used to determine the significance of the relationship between apnea frequency and occlusion pressures.
Some data from 10 of these infants has been previously reported (6) (incidence of periodic breathing and relationship between periodicity and apnea).
RESULTS
The 20 infants were studied commencing at a mean age of 3.8 h (range 2 to 8). Their mean birth weight was 1012 g (SD 322) and mean gestation was 29.7 wk (SD 2.7). Thirteen infants were delivered by the vaginal route and seven by cesarean section. The first head ultrasound revealed six infants with subependymal hemorrhages. Two of these infants progressed to small intraventricular hemorrhages. Three infants required supplemental oxygen when first entered into the study to maintain an SpOz of greater than 92%; all were in room air by 12 h of age.
All infants in the study experienced significant apneic spells before 24 h of age. The mean age of the first recorded apnea was 8.5 h (SD 3.6, range 3 to 18), which was a mean of 4.7 h (SD 4.0) after initiating the recording. The daily distribution of apneic spells is shown in Figure 1 . When the daily apnea rates were compared, there was a significant difference in total apnea fre- Thirteen of the infants were diagnosed as having clinical apnea during the 1st wk of life and all were treated with theophylline. Seven of the infants therefore had recordings for the entire 1st wk of life. None of the infants were removed from the study before d 4, three were excluded on d 5, seven on d 6, and three on d 7. There were no significant differences in apnea frequency or apnea subtype distribution between d 4 and d 7.
We wished to determine whether there was a threshold number, or duration, of apneic spells that would trigger clinical recognition of apnea and subsequent treatment. On d 4, 5, and 6 of the study there were, therefore, a group of infants who received therapy the next day (and were then removed from the study) and a group of infants that were not treated next day. On each of the 3 d, the "not treated next day" infants included the seven who never received therapy (Table 2) . Apnea frequency was therefore compared between the groups, using a t test with Bonferroni correction. There were no significant differences on d 4, 5, or 6. Eight of the 13 treated infants had a work up for sepsis that included a complete blood count, blood culture, and spinal tap. All cultures were negative.
Airway occlusion studies were performed in 16 infants. The first study was performed at a mean postnatal age of 7 h and preceded the first recorded apnea in 12 of the infants. There was a progressive nonsignificant increase in the Pal from the first to the last day of the study. There was a significant negative association (r = -0.57, p < 0.05) between the apnea frequency over the first three days and Pol measured at the time of the first occlusion study, but a very wide scatter prevents this from being a useful predictive test (Fig. 2) .
DISCUSSION
There was a 100% incidence of significant apnea in this study during the first 24 h of life. This contrasts with studies that used either brief (4) recordings or none at all (2) and emphasizes the importance of both continuous recordings and airflow monitoring for studies on apnea. Our findings imply that there is a 95% probability that 85% or more of clinically healthy infants of less than 34 wk gestation will have apneic spells on the first day.
We have performed a number of comparisons of our unique, purpose written programs with paper recordings at each state of development. These evaluations have demonstrated that significant apneic spells are not missed and many artefacts that a fully automated method could record as apneas are eliminated. The use of a single nasal detector could lead to problems if mouth opening or nasal blockage occurred; however, the requirement for hypoxia or bradycardia, in addition to the loss of nasal airflow, to diagnose an apnea makes this an unlikely cause for confounding of our results.
There is no generally accepted definition of what constitutes a significant apneic spell; investigators in recent years have accepted spells of 10 (7), 15 (8, 9) , 20 (lo), or 30 (1 1) s duration regardless of the occurrence of other physiologic changes. It is also frequently stated that shorter apneas were considered to be significant if associated with either hypoxia or bradycardia. Our definition of apnea requires both a duration of at least 15 s and either hypoxia or bradycardia. If we had simply required a duration of 15 s, regardless of hypoxia or bradycardia, we would have reported an even higher incidence of early apneic spells.
The initial objective of the study was to compare the early occlusion pressures of infants who developed apnea to control infants who did not. However, in view of the absence of nonapneic infants, we revised our planned analysis of the results. We demonstrated that occlusion pressures were lower in the infants with the most frequent apneic spells before the occurrence of the first recorded apnea. This suggests that apneic spells and reduced occlusion pressures may be caused by similar factors. Previous data from adults indicate that reduced respiratory drive may occur as a result of multiple apneic episodes, because respiratory drive gradually improves after tracheostomy (12, 13) . Our data would not support the idea that occlusion pressures in premature infants are reduced secondarily to the physiologic effects of apneic spells. Airway occlusion pressures, although commonly used as an index of respiratory center output, also reflect the state of contractility of the respiratory muscles (14) ; the association between occlusion pressure and apnea severity could, therefore, be due to an effect of respiratory muscle contractility. Indeed, there may well be an association between fatigue of the diaphragm and apneic spells (1 5). We currently have no data to confirm or refute this suggestion. There is also little data on the effects of chest wall distortion on perceived occlusion pressures. It seems likely that chest wall distortion decreases measured occlusion pressures and may also be related to apneic spells because of an increase in respiratory work (16) . We did not measure chest wall movement or distortion during occlusion studies.
Our finding of early apnea confirms our previous report (6) and the suggestions of Henderson-Smart (2) and Carlo et al. (4) . The common assertion that idiopathic apnea of prematurity occurs later may be due to the use of thoracic impedance as the exclusive method of clinical apnea monitoring in neonatal nurseries. That is a method that will not detect obstructive apneas or the obstructive portion of mixed apneas. To detect the frequent obstructed breaths of preterm infants, a monitor of oronasal airflow, such as the nasal detection of expired C02, is required.
The frequency of early apnea suggests that deficient immediate postnatal adaptation is etiologically related to the spells. We postulate that reduced central respiratory drive is associated with both reduced occlusion pressures and apneic spells. Central respiratory drive is dependent upon afferent input from a number of sources (17) . We suggest that the documented suppression of the peripheral chemoreceptor during this interval, because of the sudden increase in arterial Po2 (18, 19) , could well be a cause of both reduced respiratory drive and obstructive apneas. Two convergent lines of evidence support this suggestion. First, arousal is required for termination of apneic spells in adults with obstructive sleep apnea (13) . Activity of the carotid bodies is required for arousal in adult dogs (20) and newborn lambs (2 1) subjected to progressive hypoxia. Thus, carotid body inactivity could well lead to failure of arousal and to apneas becoming prolonged and more likely to be associated with hypoxia and bradycardia.
Second, the peripheral chemoreceptors appear to be particularly important in the maintenance of upper airway muscle activity. Evidence from both adult animals (22) and newborn infants (23) supports this and would suggest that during immediate postnatal adaptation maintenance of upper airway patency would be less efficient and obstructive and mixed apnea would be more common.
We were unable to demonstrate any significant differences between infants who were removed from the study because they were treated for apnea with methylxanthines and those who remained untreated. The clinical staff was not aware of the results of the computer analysis and the question of what prompted the clinicians to treat apnea remains unresolved. We assume that either the reporting of the apneic spells by the bedside nurse to the physician may have differed or the threshold that individual physicians used to treat apnea may have varied. Because of the lack of agreement concerning the outcome of infants who experience apnea of prematurity (24, 25) , it is inevitable that such differences will persist. Further research is required to determine what severity, frequency, and type of apneic spells are associated with clinically significant impairment.
